Skip to main content

Bone Regeneration Material Market: Up-to-Date Analysis of Latest Trends in Market

 

Increasing number of orthopedic


surgeries is an important factor driving growth of the global bone regeneration materials market. According to the National Center for Biotechnology Information, in 2015, around 7,076 hospital admissions for total knee arthroplasties (TKAs) and 13,017 hospital admission for total hip arthroplasties (THAs) were reported in Brazil. Moreover, in 2015, the state of Sao Paulo registered 49% geriatrics in the Southeast region of Brazil, among which accounted 47.4% for TKAs and 53.8% for THAs.

Similarly, the increasing incidence of osteoarthritis among the global population is expected to drive growth of global bone regeneration materials market during the forecast period. According to data published by the Arthritis Foundation in November 2017, arthritis was the leading cause of disability among adults in the U.S. Over 53 million adults worldwide suffered from arthritis, which included over 100 types of joint diseases. This is expected to increase 49% to reach over 78.4 million by 2040.

Moreover, the increasing demand for allografts, xenografts, and various other synthetic bone grafts that are innovative substitutes for real bones is expected to facilitate the market growth. For instance, use of hydroxyapatite in bone grafts without any organic and biological agents obstructs natural processes such as osteogenesis, osteoconduction, and osteoinduction, as they are made through recombinant DNA technology.

Global Bone Regeneration Materials Market - Impact of Coronavirus (COVID-19) Pandemic

The spread of the novel coronavirus has hampered growth of the healthcare industry. In December 2019, in China’s Wuhan City, a cluster of pneumonia cases were reported by Chinese health authorities. The pneumonia causative agent was identified as a novel coronavirus named COVID-19. This virus spread rapidly across the globe, thus causing a concerning number of fatalities. In March, 2020, the World Health Organization (WHO) declared the COVID-19 as a global pandemic and suggested implementation of strict measures to minimize the spread of this disease. The pandemic has slowed down growth of the healthcare sector and led to a disturbance in the supply chain.

Moreover, governments across various countries have implemented nationwide lockdowns to curb the spread of COVID-19. Similarly, in various countries across the world, healthcare companies are facing problems of continuing its supply chain operations. The slowdown of the healthcare companies’ supply chain has also impacted growth of Global Bone Regeneration Materials Market.

Global bone regeneration materials market is estimated to be valued at US$ 2292.1 million in 2020 and is expected to exhibit a CAGR of 3.3% during the forecast period (2020-2027).

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more